Hans-Peter Hasler, Director at Shield Therapeutics, holds 5.50M shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Hans-Peter Hasler Bought 2,000,000p shares of Shield Therapeutics on Nov 27, 2023 for an estimated value of 122.00K.
What is the percentage of profitable transactions made by Hans-Peter Hasler?
The percentage of profitable transactions made by Hans-Peter Hasler is 0%.
What is the average return per transaction made by Hans-Peter Hasler?
The average return per transaction made by Hans-Peter Hasler is -27.40%.
What stocks does Hans-Peter Hasler hold?
Hans-Peter Hasler holds: GB:STX stocks.
What was Hans-Peter Hasler’s latest transaction?
Hans-Peter Hasler latest transaction was an Informative Buy of 122.00K.
What was Hans-Peter Hasler's most profitable transaction?
Hans-Peter Hasler’s most profitable transaction was an Informative Buy of GB:STX stock on December 13, 2022. The return on the trade was -5.10%.
What is Hans-Peter Hasler's role in Shield Therapeutics?
Hans-Peter Hasler's role in Shield Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.